IGC - Rasio utang marang kapitalisasi buku India Globalization Capital

The closed patent portfolio of IGC Pharma, Inc. (IGC) for Alzheimer's therapy creates significant barriers to entry. After verifying the debt-to-capitalization ratio on GURU.Markets, we see that the 0.17 mark reflects the latest data. This confirms the potential for superprofits upon mass production of drugs, while the development of a cannabinoid product line to improve patient quality of life provides the company with an active growth phase.

To build a resilient portfolio, I evaluate an issuer's solvency through the total liabilities-to-equity ratio. This metric measures the extent of a business's reliance on borrowed funds relative to its net assets. For IGC Pharma, Inc. (IGC), this balance is critical due to the high risks associated with developing specialized neurological drugs. By analyzing the capital structure trend—debt to book capitalization—an investor can identify bankruptcy threats in advance.